RYTHROCYTES and megakaryocytes arise from the same committed progenitor"' and share many features in common. Indeed, regulation of genes expressed specifically, either in megakaryocytes or in erythrocytes, has been shown to be driven by transcription factors common to both lineages. For example, it is well established that GATA-1, a central regulator of erythropoiesis,4 is also active in megakaryocytes and in mast cells.*. ' The finding that other important transcription factors such as Tal-I/SCL7.8 and NFE2,9 which were first discovered in the erythroid lineage, were also coexpressed in megakaryocytes have suggested that the control of the gene expression program in these two lineages is probably very similar.
Despite all of these similarities, megakaryocytes and erythrocytes are able to establish their own specific pattern of gene expression leading to mature cells that express different specific markers and that are dedicated to different specialized functions. We have used the promoter of platelet glycoprotein (GPIIb), an early and specific marker of megakaryocytes,'" as a target sequence for the characterization of regulatory cis-acting sequences of GPIIb gene. Our studies"~'4 and those of other g r o~p s '~. '~ suggest that the transcription factors that bind to positive controlling elements are not megakaryocyte-specific. Two transcription factors were found to exert a dominant effect on the activity of the GPIIb binding to at least four GATA elements that exhibit various E promoter.13.14.16. 17 The first one, GATA-I, acts through the GPllb promoter elements active in the megakaryocytic HEL, the erythroid K562, the monocytic U937, or the nonhematopoietic HeLa cell lines, indicating that it controls GPllb gene tissue specificity. In addition, direct evidence for tissue-specific interaction between this repressor and the GPllb -5981 -406 enhancer was obtained when these elements were set in the context of a heterologous SV40 promoter. Interestingly, the same repressor element controlling tissue specificity of the GPllb gene may also control its temporal expression during megakaryocyte differentiation, based on recent evidence obtained by Fong and Santoro (J Biol Chem 269:18441,1994). Finally, wefoundthatthe -120/-116GPllb sequence was part of a consensus motif shared by promoters of other megakaryocyte-specific genes, suggesting a common repressor mechanism. 0 1996 by The American Society of Hematology. levels of positive transcriptional activity. In particular, the GATA site located at position -463 has proven to be crucial for full promoter activity. The second important transcription factor is a member of the Ets family, but is still unidentified. Two of the Ets binding sites seem to be associated to a GATA element. This GATAEts association is not unique to the GPIIb promoter, because such combination was found in most promoters of megakaryocytic genes that have been isolated and sequenced.''." This was consistent with the model in which the two elements, although not individually megakaryocyte-specific, could act in concert to confer cell specificity to the megakaryocytic genes. In addition to this combinatorial effect of cis-acting elements, another promoter domain described by Fong and Santoro** may contribute to the control of the GPIIb gene. They propose that the -198/ -99 region of the GPIIb promoter may act as a repressor domain inactivated during the megakaryocytic differentiation of K562 cells induced by phorbol dibutyrate. No study was conducted to decipher the respective roles of the GPIIb promoter elements in the negative control of tissue-specificity.
In the present report, we show that mutations of the GATA and/or Ets binding sites do not affect the tissue specificity of the GPIIb promoter. In contrast, alteration of a domain located between -118/-93 relieves the block of the transcriptional activity of the GPIIb promoter in nonmegakaryocytic cells. Consistent with this repressor activity, this domain is able to extinguish the GATA/Ets-containing -5981 -406 enhancer in a heterologous promoter context. Importantly this tissue-specific repressor region overlaps with the -198/-99 domain identified by Fong and Santoro," which they found to be important for the activation of the GPIIb gene during megakaryocyte differentiation. This suggests that both the temporal activation of the GPIIb gene and its cell specificity may be controlled by the same transcriptional regulators.
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The different GPIIb pBLCAT3 constructs were obtained after unidirectional deletions, as already de~cribed.'~ They contained the human GPIIb promoter sequence starting from position +33 (relative to the transcription start site + l ) to -813, -414, -170, -142, -113, -73, -29, and -13, respectively. Mutations of GATA (-463) and Ets (-515) sites individually or together in the -813 Ilb construct and mutation of GATA (-54) have been already de~cribed?,'~ Mutations of the -40 Ets site individually or in combination with the -54 GATA site were also designed.
The series of mutants of the -414 GPIIb promoter described in Fig 3 and CAT assays. CAT assays were performed as described by Gorman et Acetylation of '"[C] chloramphenicol was determinated by quantitating the radioactivity on thin-layer chromatography plates and scintillation counting. CAT activity correspond to the percentage of conversion of chloramphenicol to acetylated forms. All assays were performed within the linear range of the acetylation reaction.
DNase I protection assays. DNase I protection assays were performed as already described" using nuclear extracts from HEL, K562, and HeLa cells. The DNA probe corresponding to the GPIIb gene 5' flanking region extending from -357 to +33 was endlabeled at position +33 with 32P-adCTP by the Klenow filling reaction. The labeled probe was separated from the plasmid on a 2% agarose gel and electroeluted.
RESULTS
GATA and Ets cis-acting elements are not involved in the control of GPIIb promoter cell specifcity. We and others have established that GATA binding sites located at position -463 and -54 and the Ets motifs located at position -515 and -40 are implicated in GPIIb promoter function.I4.l7 To analyze the contribution of the GATA and Ets binding sites to the cell specificity of the GPIIb promoter, we mutated each site, individually or in combination (Fig 1) . These mutants were then transfected in HEL, K562, and HeLa cells and the resulting CAT activities were measured; pBLCAT3 was used as negative control. Results are summarized in Fig  1 . As previously described, the mutation of the -515 Ets and the -463 GATA sites produced a twofold decrease in the promoter activity in the megakaryocytic HEL cell line. Similarly, mutations of the -54 GATA site and the -40 Ets site, individually or in combination, did induce a comparable, although less pronounced, decrease in the promoter activity in these cells.
When these different mutants were transfected in the nonhematopoietic HeLa cell line, no increase in CAT activity was observed, compared with the wild-type IIb construct; likewise, no increase in CAT activity was observed when constructs with mutations of GATA and/or Ets elements were transfected in K562 cells. Taken together, these results suggest that the -463 and -54 GATA sites and the -515 and -40 Ets binding sites do not play a major role in the cell specificity of GPIIb promoter.
Loss of specificity of the GPIIb promoter in HeLa cells: Analysis by deletion. To delineate the promoter regions implicated in the regulation of the cell specificity, we have generated 5' progressive deletions, starting from the -414 IIb pBLCAT3 plasmid. Five promoter fragments starting fromposition +33 andextending to -170, -113, -73, -29, and -13, respectively, were generated. The ability of these promoter fragments to drive the cell specificity of the CAT reporter gene was examined by comparative transfections in HeLa and in HEL cells (Fig 2) . The CAT activity obtained with the -414 construct in HeLa cells was within the range of the background level (3.5% v 2.2% with the promoterless plasmid pBLCAT3). As the promoter sequence was progressively deleted from its 5' end, CAT activity increased in HeLa cells. This CAT activity in HeLa cells reached a maximum (35%) after deletion of the -113/-73 region. These results suggested that this sequence contained an element implicated in the control of the cell specificity of GPIIb gene expression. Further deletions resulted in a decrease of the CAT activity, with the remaining basal activity (14.2%) being most likely due to a SP1 binding site present in the -13/+33 region. When the same deleted constructs were transfected in HEL cells, we observed that deletion of the -1 13/-73 region increased the CAT activity from 11.2 to 23.2. This suggests that the -1131-73 region has a slight repressor activity in HEL cells.
Scanning of the repressor domain by substitutive mutagenesis. The 5' deletion experiments strongly suggested that the -113/-73 region contained a repressor element controlling the cell specificity of the GPIIb promoter. To confirm this hypothesis and to localize more precisely this repressor, the sequence extending from -139 to -63 was scanned by substitutive mutagenesis. Promoter fragments 15-to 25-bp long were replaced by unrelated sequences of the same size. As opposed to deletion analysis, this approach allowed the study of the specific function of this promoter domain in the context of the preserved -414/+1 region overall structure. The constructs described in Fig 3 were transfected in HeLa cells, and the corresponding CAT activities were measured. The -821-63 and the -89/-74 constructs exhibited CAT activities (5% and 2%, respectively) within the range of the basal CAT activity given by the wild-type -414 construct (3.5%). In contrast, CAT activity increased in the next three mutants, reaching a maximum for the -1 18/-93 and the -137/-117 mutants (65% and 57%, respectively). Finally, the CAT activity decreased to basal level with the -139/ -121 (3.5%). Thus, the repressor activity in HeLa cells is located in the region encompassing positions -120 to -93.
To point out precisely the sequences involved in the repressor function, three additional mutations were introduced in the -1201-93 region (Fig 3) and transfected in HeLa cells. Analysis of the CAT activities showed that the -120/ -1 16 and the -102/-93 mutants induced 52% and 26% CAT activity, whereas the -l IO/-99 was less active (12%).
To assess an additive effect of the -120/-116 and the -102/ -93 regions, the corresponding mutations were introduced in the -414 construct. A CAT activity of 79% was observed that is higher than that obtained when these mutants were studied independently. Footprint analysis of the repressor region. We then asked if nuclear factors interacted with the repressor region.
A DNA fragment containing sequence from -357 to +33 was analyzed by DNase I footprinting assays with nuclear extracts from HEL, K562, and HeLa cells. In Fig 4, gives footprints in all cell lines. No consensus sequence was found in this region. Finally, a small footprint, weak but reproducible, was found in the -120/-116 region. As shown above, this footprint corresponds exactly to the -1201-116 mutant that induced an important CAT activity in HeLa cells, confirming that this region was involved in the repressor activity. Contrasting with this result, no obvious footprint could be detected in the -1021-93 region, the other part of the repressor, as defined by the functional studies.
The repressor modulates positive cis-acting elements in a tissue-specific manner. In the preceding experiments, we have examined the repressor activity in the -414 promoter fragment in HeLa cells. We then examined the role of the proposed repressor region in constructs having either 813, 414, or 142 bp of 5' flanking region. Transient expression studies were performed in HeLa, U937, K562, and HEL cells to check for tissue specificity. In HeLa cells (Fig 5 ) , a significant increase in CAT activity (13.5% instead of 1.6%) was obtained after mutation of the repressor in the -813 construct, confirming the presence of a repressor activity in these cells. A dramatic activity increase (65% v 3.5%) was obtained with the mutated -414 construct. The repressor mutation still induced an activity increase with the -142 construct, but not as marked (12% v 3.8%). This confirms the existence of a strong repressor activity in HeLa cells, but also suggests the presence of potent positive elements in the -414/-142 sequence, which are active in HeLa cells only after the deletion of upstream enhancer-containing sequences. Similar results are obtained with the different constructs in the myeloid U937 cells.
In K562 cells, a significant repressor activity was also shown based on the marked activity increase obtained by the repressor mutation in all 3 constructs. This activity was maximal in the -8 13 construct, confirming our previous r e s~l t s '~ showing that the -5981-406 enhancer is active in K562 cells. The -4141-142 sequence did not exhibit any positive transcriptional activity after deletion of upstream sequences, as opposed to HeLa cells or U937 cells. In HEL cells, mutation of the repressor in the -813 fragment, which contains the -5981-406 enhancer element, did not induce any CAT activity increase (53% v 56%). In contrast, in the -414 construct, which does not contain the enhancer, a significant CAT activity increase after repressor mutation was observed (36% v 18%). This suggests that, in the megakaryocytic HEL cells, the repressor activity is present but overridden by the enhancer. Deletion of the -4141-142 sequence results in a decrease of the CAT activity in the mutated constructs (36% v 11%).
Direct effect of the repressor on a composite promoter containing the SV40 promoter and the GPIIb enhancer. The repressor region was introduced in the pCAT plasmid containing the GPIIb enhancer inserted in direct orientation downstream to the CAT gene, which is driven by the enhancerless SV40 promoter. A -242/-74 repressor-containing domain was inserted in direct orientation between the CAT gene and the enhancer (Fig 6) . As previously described,I3 the -598/-406 enhancer alone was able to augment the SV40 basal activity 5.2-and 4.6-fold in HEL and K562 cells, respectively, whereas it remained at basal level in HeLa cells. The addition of the repressor element resulted in a moderate decrease in the enhancer activity in HEL cells.
In contrast, in K562 cells, the repressor strongly inhibited the enhancer function, because a decrease from 4.6-to 1.5-fold was obtained. In HeLa cells, because the enhancercontaining construct was not active, addition of the repressor did not affect the CAT activity. These results confirm that the repressor acts on promoters unrelated to its original context. In addition, they show that this repressor interferes directly with the enhancer function.
DISCUSSION
One of the major intriguing problems in hematopoiesis is how lineage-specific patterns of gene expression may arise from a common precursor cell. The problem appears even more complex with respect to the megakaryocyte differentiation, because common features are exhibited between megakaryocytes and erythrocytes at different levels along the differentiation path. For example, several transcription factors, such as GATA 1, Tal I , and NFE2, are detected in both line a g e~. "~ Strong evidence for the implication of GATAl in the regulation of the transcription of the GPIIb gene and of many megakaryocytic was provided by functional experiments in megakaryocytic cell line^'^.'^ or in megakaryocytes obtained from rat bone marrow primary cultures.'' However, knock-out experiments have not shown any direct link between GATAl and megakaryocytic differentiati~n.~.'~ In contrast, although binding sites for the transcription factor NFE2 are present in the promoters, enhancers, and locus control region (LCR) of many erythroid genes:x-" inactivation of the P45 NFE2 gene has only a mild effect on erythrocytic differentiation, but totally prevents the terminal differentiation of megakaryocytes."
The megakaryocyte-specific GPIIb was shown to be transcriptionally active in erythro-megakaryocytic stem cells and early erythroblastic progenitors3'.'' but inactive in mature erythrocytic cells, suggesting that transcription of this gene might be regulated negatively during erythropoiesis. GATA and Ets elements, the association of which seems to be determinant to megakaryocyte-specific gene expression, could represent good candidates for a negative regulation of GPllb expression in nonmegakaryocytic cell lines. Supporting this hypothesis is the observation that the p-and the €-globin transcription is positively or negatively controlled by GATA-1, depending on the developmental c~ntext.~'"~ To assess a potential negative role of the GATA and Ets elements, we mutated the active GATA and Ets binding sites previously identified in the GPIIb promoter individually or in combination. As expected, these mutations suppressed the GPIIb promoter transcriptional activity in megakaryocytic HEL cell line. However, they did not induce any transcriptional CAT reporter activity in HeLa or K562 cells. No direct repressor activity could be attributed to the GATA or Ets binding sites in the GPIIb promoter, thus suggesting the presence of other negative regulators. We undertook a survey of such elements involved in the tissue specificity of the GPIIb genc cxprcssion by monitoring thc cxprcssion of progressively deleted GPlIb constructs in the nonhematopoietic cell line HeLa. These experiments allowed us to delineate a region located between -170/-73 that behaves as a repressor because its deletion relieved the transcriptional block in HeLa cells. Interestingly, HEL cells exhibited some repressor activity upon deletion of the same region.
To localize more precisely the repressor in the context of an intact promoter, we undertook the scanning mutagenesis of the -139/-63 region that created minimal (15-to 25-bp long) local sequence changes in the promoter. Overlap analysis of the 10 constructs tested designated the -120/-93 GPIIb promoter region as directly involved in the negative control of the cell specificity. Indeed, mutagenesis of the -120/-116, -1 IO/-99, and -102/-93 sequences (Fig 3) showed that the combined -I20/-1 I6 and -102/-93 mutations led to the strongest transcriptional activity. This sug- -93 mutation (empty box) and extending from +33 to -813, -414 and -142 respectively, were transfected in Heb, U937, W , and HEL cells. CAT activities were measured 48 hours after transfection. All experiments were normalized for transfection efficiency by using luciferase activii. CAT activities represent an average of at least four separate transfections.
gests that these two distinct domains are required for full repressor activity. Footprint analysis of the -357/+33 region with extracts from the nonhematopoietic HeLa cells, the erythroid K562 cells, and the megakaryocytic HEL cells allowed us to describe at least five domains between -206 and -1 16. The footprinted -152 to -135 region displayed a perfect Ets consensus binding site (-136/-1 4 4 CCAGGAAGT), which is as yet undescribed. Mutation of the -1391-121 region that disrupts this site did not induce any CAT activity in HeLa cells (Fig 3) For personal use only. on September 24, 2017. by guest www.bloodjournal.org From three nuclear extracts, corresponds to the most active of the two repressor domains defined by functional studies. In contrast, no obvious footprint was observed with the other repressor domain, the -102/-93 region. One possibility is that the DNA-protein interactions in the -102/-93 are too weak to be detected with crude extracts.
As a clue to understanding the repressor mechanism and particularly in view of its potential role in the control of tissue-specificity of the GPIIb promoter, we looked for possible interactions between the repressor and other cis-acting elements as a function of cell-type. In HEL and K562 cells, deletion of the enhancer in the mutated-repressor promoter led to a decrease of the CAT activity. In contrast, in HeLa and U937 cells, the same deletion induced an important increase of the CAT activity. This suggests that HeLa and U937 cells express positive transcription factors capable of driving GPIIb transcription and that the enhancer could behave like an accessory repressor in these cells. In the absence of enhancer, removal of the repressor region (by deletion or mutation) induces a twofold enhancement in HEL cells. This indicates that the transcription factors that bind to the repressor are present and moderately active in the HEL cell line. This is in agreement with our finding that the -120/-116 region is footprinted in HEL cells and with the observation by Block et a1.I6 These investigators have shown by transfection of primary cultured rat megakaryocytes that deletion of the -150/-101 region in the rat GPIIb promoter also increased the transcriptional activity and, as such, behaved like a repressor. A tempting explanation for this phenomenon is that, in HEL cells, the repressor is smothered by the positive elements of the promoter and, in particular, by the enhancer, eg, by proteidprotein interactions specific of the megakaryocytic context. In this model, in cells in which the enhancer is not functional, such as in HeLa cells or in the monocytic cell line U937, the repressor is fully active. In contrast, in erythroid K562 cells, the enhancer, which is transcriptionally active (as shown in the context of the heterologous SV40 promoter; Fig 6) , does not inactivate the repressor. The mechanism by which the same functional enhancer element affects differently the repressor in HEL and K562 cells is unknown. One possible explanation is that differences exist in DNA binding factors interacting with either the enhancer or the repressor elements. Further investigations are needed to test this hypothesis. Nevertheless, it is likely that the key to the control of the megakaryocytic specificity of the GPIIb gene transcription lies in the enhancerirepressor interaction.
Interestingly, the (-120/-116)(-102/-93) repressor that we found involved in the negative control of the GPIIb promoter cell specificity overlaps with the -124/-99 domain identified by Fong and Santoro." These investigators suggest that this domain is involved in the temporal activation of the GPIIb gene transcription during the course of megakaryocytopoiesis. Thus, tissue specificity of the GPIIb gene (ie, its transcriptional block in all nonmegakaryocytic tissues) and its temporal activation during megakaryocytopoiesis (ie, transcriptional activation in the course of megakaryocytic differentiation) may be controlled by the same repressor element. However, several differences between the two studies must be emphasized. We observed that the repressor region was footprinted in the megakaryocytic HEL cell line, whereas Fong and Santoro2* showed that megakaryocytic induction by phorbol ester in K562 cells led to loss of DNA binding activity in the same area. A possible explanation for this difference is that HEL cells and phorbol-induced K562 cells may represent different stages in the megakaryocyte differentiation pathway. Another difference is that we were unable to show a repressor effect on the heterologous SV40 promoter because, in our hands, it exhibited very little basal transcriptional activity in K562 cells. This is in contrast with the findings of Fong and Santoro,2Z who, in a similar experiment, obtained a strong transcriptional signal that was abrogated by the repressor. Distinct K562 clones used in the two studies may account for this difference. Aside from these differences, both studies are convergent and consistent with the concept that the regions (and possibly the mechanisms) involved in the control of the tissue-specificity and the temporal expression of the GPIIb gene are probably either identical or closely related.
A number of a chain integrin promoters have been studied. Among them, the a2 promoter has been the most extensively studied functionally, and a repressor element was also localized.'* No obvious homologies can be found with the GPIIb repressor, but this observation suggests that the integrin gene expression may be regulated by an interplay of enhancers and repressors.
Finally, it is of potential importance that we found that the most active repressor sequence, ie, the -120/-1 16 sequence, was present in the promoter of the human PF4 gene in a region recently characterized as a repressor by Ramachandran et aL3' Moreover, a core CATGAG sequence (-12 l / -1 16) was also found in a number of other megakaryocytic promoters (Table l) , among which one, GPIba, was characterized functionally." Although no repressor has been shown yet in the GPIba promoter, we note that the CATGAG sequence maps within the -253/-73 transcription control region upstream of functional Ets and GATA sites. This location is reminiscent of the position of the repressor in the For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
